Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A 52-week, open label, parallel group, multicentre, phase III, randomised controlled trial to compare the efficacy and safety of Budesonide/formoterol turbuhaler taken as required for relief of symptoms and Budesonide turbuhaler as maintenance and terbutaline turbuhaler as required for relief of symptoms of asthma in adults

X
Trial Profile

A 52-week, open label, parallel group, multicentre, phase III, randomised controlled trial to compare the efficacy and safety of Budesonide/formoterol turbuhaler taken as required for relief of symptoms and Budesonide turbuhaler as maintenance and terbutaline turbuhaler as required for relief of symptoms of asthma in adults

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 08 Oct 2020

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Budesonide (Primary) ; Budesonide/formoterol (Primary) ; Terbutaline (Primary)
  • Indications Asthma
  • Focus Therapeutic Use
  • Acronyms PRACTICAL
  • Most Recent Events

    • 12 Aug 2020 Results of a subgroup analysis assessing the nfluence of ethnicity on the efficacy of as-needed budesonide-formoterol vs maintenance budesonide and as-needed terbutaline published in the New Zealand Medical Journal
    • 27 Jul 2020 Results of subgroup analysis from the PRACTICAL study(n=407) detrming Discrete choice experiments in asthma patients, published in the Thorax

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top